Publication: Understanding anti-leukemia responses to donor lymphocyte infusion
Open/View Files
Date
2014
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Landes Bioscience
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Bachireddy, Pavan, and Catherine J Wu. 2014. “Understanding anti-leukemia responses to donor lymphocyte infusion.” Oncoimmunology 3 (1): e28187. doi:10.4161/onci.28187. http://dx.doi.org/10.4161/onci.28187.
Research Data
Abstract
Donor lymphocyte infusion (DLI) is an established and potentially curative immune therapy for relapsed leukemia after hematopoietic stem cell transplant (HSCT). Herein, we describe the utility of DLI as a tractable model system to glean fresh insights into understanding and predicting effective anti-leukemia immunity.
Description
Other Available Sources
Keywords
T cell exhaustion, donor lymphocyte infusion, CML, stem cell transplantation, tumor-infiltrating lymphocytes
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service